AMERICAN INTERNATIONAL GROUP, INC. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2018$196,000
-22.2%
84,091
-5.1%
0.00%0.0%
Q4 2017$252,000
+8.6%
88,614
+9.2%
0.00%0.0%
Q3 2017$232,000
+25.4%
81,138
+8.1%
0.00%0.0%
Q2 2017$185,000
-12.7%
75,072
+27.6%
0.00%0.0%
Q1 2017$212,000
+8.7%
58,838
+7.1%
0.00%0.0%
Q4 2016$195,000
-99.9%
54,958
-0.3%
0.00%0.0%
Q3 2016$222,604,000
-7.8%
55,100
+0.2%
0.00%0.0%
Q2 2016$241,520,000
+4.6%
55,016
-10.0%
0.00%0.0%
Q1 2016$231,000,000
-76.0%
61,125
-0.3%
0.00%
-75.0%
Q4 2015$961,000,000
+151477.3%
61,325
+2.1%
0.00%
+33.3%
Q3 2015$634,000
-100.0%
60,088
-0.3%
0.00%
-50.0%
Q2 2015$1,519,984,000
-7.4%
60,269
+2.4%
0.01%
-14.3%
Q1 2015$1,640,791,000
+54.9%
58,873
+1.4%
0.01%
+40.0%
Q4 2014$1,059,487,000
+35.4%
58,054
-3.8%
0.01%
+66.7%
Q3 2014$782,486,000
-19.8%
60,377
+0.9%
0.00%
-25.0%
Q2 2014$976,263,000
-9.9%
59,820
-2.4%
0.00%
-20.0%
Q1 2014$1,083,400,000
-25.2%
61,313
+2.4%
0.01%
-28.6%
Q4 2013$1,449,139,000
-27.0%
59,857
+6.8%
0.01%
-36.4%
Q3 2013$1,985,001,000
+129.0%
56,026
+0.9%
0.01%
+120.0%
Q2 2013$866,636,00055,5180.01%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2016
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 1,025,000$24,815,00031.36%
TSP Capital Management Group, LLC 836,342$20,248,0008.80%
Iguana Healthcare Management, LLC 200,000$4,842,0002.76%
First Light Asset Management, LLC 116,096$2,811,0002.38%
SECTORAL ASSET MANAGEMENT INC 2,227,688$53,932,0002.33%
BENNETT LAWRENCE MANAGEMENT L L C/NY 550,735$13,334,0002.05%
Eventide Asset Management 257,000$6,222,0001.92%
Redmile Group, LLC 397,951$9,634,0001.19%
ARDSLEY ADVISORY PARTNERS LP 357,000$8,643,0001.15%
Rhenman & Partners Asset Management AB 90,000$2,179,0000.85%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders